Bevacizumab 63552-0113
Product NDC
63552-0113- Manufacturer
- Patheon Manufacturing Services Llc
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- February 26, 2004
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bevacizumab | 100 mg/4mL |
Packaging Options(1)
77 VIAL in 1 CASE (63552-113-00) / 4 mL in 1 VIAL